Aramore Selected as a 2026 BeautyMatter NEXT50
Recognition solidifies Aramore's breakthrough scientific approach to skin longevity and performance.
Recognized for its vision, innovation, and scientific credibility, Aramore continues to stand out as a distinguished newcomer in a crowded category. Aramore's technology zeroes in on NAD+, the energy source for our mitochondria, which powers skin's energy production, ability to repair, and cellular renewal.
Aramore's NAD+
"This recognition from BeautyMatter is an exciting milestone for Aramore and reflects the passion, creativity, and dedication of our entire team," said
BeautyMatter's NEXT50 highlights companies that demonstrate exceptional momentum, differentiated positioning, and the potential to influence the future of beauty. This recognition reflects Aramore's continued growth and commitment to innovation and research-backed formulations.
ABOUT ARAMORE:
Aramore was founded at the intersection of biotechnology and beauty by a team of experts united by a shared belief: that the future of skincare lies in supporting skin performance at the cellular level, not treating the surface-level symptoms of aging. Backed by research and leadership from Harvard and MIT scientists, the brand's NAD+ Precursor Complex is the result of years of research and development, engineered to restore skin to its peak performance, and providing transformative results not just in how skin looks, but how it behaves.
For more information, visit aramoreskincare.com or follow @aramoreskin.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aramore-selected-as-a-2026-beautymatter-next50-302815038.html
SOURCE ARAMORE Skincare
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation, Family Dental Care Experts Dr. Joseph T. Sumrall and Dr. Gran Sumrall of Warner Robins, GA, Explain Why Cosmetic Dental Changes Focus on Looking Natural
- The World's Leading Cause of Death Is Finally Becoming a Global Conversation. AnginaX Is Helping Build What Comes Next
- MMJ Federal Challenges Put Trump Administration's Marijuana Rescheduling Shortcut at Risk
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share